Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Crossover PK Study of Solithromycin and Rosuvastatin in Healthy Adults
jRCT2080224614Phase 1Completed
- Sponsor
- FUJIFILM Toyama Chemical
- Start
- Mar 2019
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of solithromycin in dyslipidemia and bacterial disease, sponsored by FUJIFILM Toyama Chemical. Primary endpoint: Primary pharmacokinetic endpoints. Started Mar 2019; status: completed.
02
Drugs
solithromycin
03
Conditions
dyslipidemiabacterial disease
Beyond the preview
Go deeper on jRCT2080224614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224614.